Bristol mail room mishap permitted Geneva generic captopril approval -- BMS testimony.

BRISTOL MAIL ROOM ERROR ALLOWED GENEVA CAPTOPRIL APPROVAL, Bristol outside counsel Robert Baechtold of the New York City firm Fitzpatrick, Cella, Harper & Scinto indicated during a Nov. 11 hearing before Newark, N.J. federal court Judge John Lifland. "Because Geneva's certification was never delivered to anybody at Bristol who was responsible for captopril, we didn't know about it, we didn't sue them. If we had sued them, they certainly would not be in the market today," he asserted.